123 related articles for article (PubMed ID: 540072)
1. [Ultrastructural study on the effect of an inhibitor of platelet aggregation (author's transl)].
Le Menn R; Migne J; Probst-Dvojakovic RJ
Arzneimittelforschung; 1979; 29(8a):1278-82. PubMed ID: 540072
[TBL] [Abstract][Full Text] [Related]
2. [Nicergoline and platelet aggregation. A review of experimental and clinical studies (author's transl)].
Praga C; Tantalo V; Marangoni R
Arzneimittelforschung; 1979; 29(8a):1270-6. PubMed ID: 540070
[TBL] [Abstract][Full Text] [Related]
3. [Ultrastructural study of the action of a blood platelet anti-aggregant. Application to nicergoline].
Le Menn R; Migne J; Prost-Dvojakovic RJ
Therapie; 1977; 32(2):205-14. PubMed ID: 898128
[No Abstract] [Full Text] [Related]
4. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
5. [Effects of nicergoline on cerebral blood flow (author's transl)].
Iliff LD; Du Boulay GH; Marshall J; Ross Russell RW; Symon L
Arzneimittelforschung; 1979; 29(8a):1277-8. PubMed ID: 540071
[TBL] [Abstract][Full Text] [Related]
6. [Influence of nicergoline on the cerebral blood flow and alpha-sympatholytical properties (author's transl)].
Lievre M; Ollagnier M; Faucon G
Arzneimittelforschung; 1979; 29(8a):1227-31. PubMed ID: 44198
[TBL] [Abstract][Full Text] [Related]
7. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
Lagarde M; Guichardant M; Ghazi I; Dechavanne M
Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
[TBL] [Abstract][Full Text] [Related]
8. [Quantitative EEG examinations on the vigilance stabilizing effect of nicergoline / Results of a double blind study with gerontopsychiatric patients (author's transl)].
Bente D; Glatthaar G; Ulrich G; Lewinsky M
Arzneimittelforschung; 1979; 29(11):1804-8. PubMed ID: 543890
[TBL] [Abstract][Full Text] [Related]
9. [A review of pharmacological studies on nicergoline].
Moretti A; Arcari G; Pegrassi L
Arzneimittelforschung; 1979; 29(8a):1223-7. PubMed ID: 44197
[TBL] [Abstract][Full Text] [Related]
10. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].
Pogliani E; Recalcati P; Tantalo V; Bregnani P
Arzneimittelforschung; 1979; 29(8a):1266-9. PubMed ID: 395954
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic and neurochemical effects of nicergoline on the central nervous system. A review of the experimental studies (author's transl)].
Moretti A
Arzneimittelforschung; 1979; 29(8a):1213-23. PubMed ID: 395953
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic effects of nicergolin in man at rest and during exertion (author's transl)].
Boismare F; Lefrançois J
Arzneimittelforschung; 1979; 29(8a):1261-6. PubMed ID: 540069
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human platelet aggregation by oral administration of nicergoline. A double-blind study.
Pogliani E; Volpe AD; Ferrari R; Recalcati P; Praga C
Farmaco Prat; 1975 Dec; 30(12):630-40. PubMed ID: 1107066
[No Abstract] [Full Text] [Related]
14. Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.
Bolli R; Ware JA; Brandon TA; Weilbaecher DG; Mace ML
J Am Coll Cardiol; 1984 Jun; 3(6):1417-26. PubMed ID: 6715702
[TBL] [Abstract][Full Text] [Related]
15. [Platelet aggregation activity. Inhibitory effects of an alpha-blocking agent: nicergoline].
Migne J; Saint-Maurice JP; Santonja R; Kunz S
Sem Hop Ther; 1974 Dec; 50(10):649-55. PubMed ID: 4465915
[No Abstract] [Full Text] [Related]
16. [From ergot alkaloids to nicergoline/Chemical points of view (author's transl)].
Bernardi L
Arzneimittelforschung; 1979; 29(8a):1204-6. PubMed ID: 540064
[TBL] [Abstract][Full Text] [Related]
17. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
[TBL] [Abstract][Full Text] [Related]
18. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
Ts'ao C
Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
[TBL] [Abstract][Full Text] [Related]
19. Some haemodynamic effects of nicergoline, a new alpha-blocking agent, in the closed-chest anaesthetized dog as compared with nitroprusside and nitroglycerin.
Moore ND; Cazor JL; Leclerc JL; Saligaut C; Boismare F
Arzneimittelforschung; 1981; 31(10):1693-8. PubMed ID: 6797441
[TBL] [Abstract][Full Text] [Related]
20. Effect of nicergoline on platelet aggregation, plasma viscosity and erythrocyte deformability in geriatric patients with cerebral infarction. Preliminary report.
Nagakawa Y; Akedo Y; Kaku S; Orimo H
Arzneimittelforschung; 1990 Aug; 40(8):862-4. PubMed ID: 2122905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
